| Literature DB >> 34523383 |
Katerina Bittenglova1,2, David Habart1, Frantisek Saudek1, Tomas Koblas3.
Abstract
The success of clinical transplantation of pancreas or isolated pancreatic islets supports the concept of cell-based cure for diabetes. One limitation is the shortage of cadaver human pancreata. The demand-supply gap could potentially be bridged by harnessing the self-renewal capacity of stem cells. Pluripotent stem cells and adult pancreatic stem cells have been explored as possible cell sources. Recently, a system for long-term culture of proposed adult pancreatic stem cells in a form of organoids was developed. Generated organoids partially mimic the architecture and cell-type composition of pancreatic tissue. Here, we review the attempts over the past decade, to utilize the organoid cell culture principles in order to identify, expand, and differentiate the adult pancreatic stem cells from different compartments of mouse and human pancreata. The development of the culture conditions, effects of specific growth factors and small molecules is discussed. The potential utility of the adult pancreatic stem cells is considered in the context of other cell sources.Entities:
Keywords: ALDH; CD133; LGR5; Organoids; PROCR; adult stem cells; beta cell; beta cell regeneration; diabetes; pancreas; progenitor cells; stem cell therapy; transplantation
Mesh:
Year: 2021 PMID: 34523383 PMCID: PMC8528407 DOI: 10.1080/19382014.2021.1941555
Source DB: PubMed Journal: Islets ISSN: 1938-2014 Impact factor: 2.308